10-K Filing

JOINT Corp CIK: 1612630 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001628280-24-009767`
Period End Date	20231231
Filing Date	20240308
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	jynt-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 116 Income Statement 32 Cash Flow Statement 63 Stockholders Equity 24

Balance Sheet 116 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.75M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.15M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$805.35K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$1.06M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.72M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.91M	USD	Point-in-time
Deferred tax assets ($1.1 million and $1.0 million attributable to VIEs as of December 31, 2023 and 2022)	`DeferredIncomeTaxAssetsNet`	$11.93M	USD	Point-in-time
Deferred franchise and regional development costs, current portion	`ContractWithCustomerAssetNetCurrent`	$1.05M	USD	Point-in-time
Deferred franchise and regional development costs, current portion	`ContractWithCustomerAssetNetCurrent`	$1.05M	USD	Point-in-time
Deferred tax assets ($1.1 million and $1.0 million attributable to VIEs as of December 31, 2023 and 2022)	`DeferredIncomeTaxAssetsNet`	$1.03M	USD	Point-in-time
Payroll liabilities attributable to VIEs	`EmployeeRelatedLiabilitiesCurrent`	$3.49M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.10M	USD	Point-in-time
Payroll liabilities attributable to VIEs	`EmployeeRelatedLiabilitiesCurrent`	$2.03M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.44M	USD	Point-in-time
Deferred revenue from company clinics attributable to VIE	`ContractWithCustomerLiabilityCurrent`	$2.47M	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Deferred revenue from company clinics attributable to VIE	`ContractWithCustomerLiabilityCurrent`	$2.52M	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$17.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.61M	USD	Point-in-time
Liabilities to be disposed of ($3.6 million attributable to VIEs as of December 31, 2023)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$44.34M	USD	Point-in-time
Liabilities to be disposed of ($3.6 million attributable to VIEs as of December 31, 2023)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$13.83M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$17.48M	USD	Point-in-time
Series A preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series A preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$11.04M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$12.41M	USD	Point-in-time
Series A preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	50,000.00	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$20.59M	USD	Point-in-time
Series A preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	50,000.00	shares	Point-in-time
Deferred franchise and regional development costs, net of current portion	`ContractWithCustomerAssetNetNoncurrent`	$5.20M	USD	Point-in-time
Series A preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Series A preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Deferred franchise and regional development costs, net of current portion	`ContractWithCustomerAssetNetNoncurrent`	$5.71M	USD	Point-in-time
Series A preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Series A preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.02M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$10.93M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Goodwill	`Goodwill`	$7.35M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Goodwill	`Goodwill`	$8.49M	USD	Point-in-time
Deferred tax assets ($1.1 million and $1.0 million attributable to VIEs as of December 31, 2023 and 2022)	`DeferredIncomeTaxAssetsNet`	$11.93M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	20.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	20.00M	shares	Point-in-time
Deferred tax assets ($1.1 million and $1.0 million attributable to VIEs as of December 31, 2023 and 2022)	`DeferredIncomeTaxAssetsNet`	$1.03M	USD	Point-in-time
Deposits and other assets	`DepositsAssetsNoncurrent`	$756.39K	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	14.56M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	14.78M	shares	Point-in-time
Deposits and other assets	`DepositsAssetsNoncurrent`	$748.39K	USD	Point-in-time
Total assets	`Assets`	$93.49M	USD	Point-in-time
Total assets	`Assets`	$87.15M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	14.53M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	14.75M	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockCommonShares`	32,124.00	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockCommonShares`	31,866.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.63M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.97M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.07M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.96M	USD	Point-in-time
Co-op funds liability	`CoOpFundsLiabilityCurrent`	$1.06M	USD	Point-in-time
Co-op funds liability	`CoOpFundsLiabilityCurrent`	$805.35K	USD	Point-in-time
Payroll liabilities ($0.7 million and $0.6 million attributable to VIEs as of December 31, 2023 and 2022)	`EmployeeRelatedLiabilitiesCurrent`	$3.49M	USD	Point-in-time
Payroll liabilities ($0.7 million and $0.6 million attributable to VIEs as of December 31, 2023 and 2022)	`EmployeeRelatedLiabilitiesCurrent`	$2.03M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$5.30M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$3.76M	USD	Point-in-time
Finance lease liability, current portion	`FinanceLeaseLiabilityCurrent`	$24.43K	USD	Point-in-time
Finance lease liability, current portion	`FinanceLeaseLiabilityCurrent`	$25.49K	USD	Point-in-time
Deferred franchise fee revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$2.47M	USD	Point-in-time
Deferred franchise fee revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$2.52M	USD	Point-in-time
Deferred revenue from company clinics ($1.6 million and $4.7 million attributable to VIEs as of December 31, 2023 and 2022)	`ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance`	$7.47M	USD	Point-in-time
Deferred revenue from company clinics ($1.6 million and $4.7 million attributable to VIEs as of December 31, 2023 and 2022)	`ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance`	$5.24M	USD	Point-in-time
Deferred revenue from company clinics ($1.6 million and $4.7 million attributable to VIEs as of December 31, 2023 and 2022)	`ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance`	$4.46M	USD	Point-in-time
Upfront regional developer fees, current portion	`UpfrontRegionalDeveloperFeesCurrent`	$487.25K	USD	Point-in-time
Upfront regional developer fees, current portion	`UpfrontRegionalDeveloperFeesCurrent`	$362.33K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$597.29K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$483.25K	USD	Point-in-time
Liabilities to be disposed of ($3.6 million attributable to VIEs as of December 31, 2023)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Liabilities to be disposed of ($3.6 million attributable to VIEs as of December 31, 2023)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$13.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.22M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.57M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$10.91M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$18.67M	USD	Point-in-time
Finance lease liability, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$63.51K	USD	Point-in-time
Finance lease liability, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$38.02K	USD	Point-in-time
Debt under the Credit Agreement	`LineOfCredit`	$2.00M	USD	Point-in-time
Debt under the Credit Agreement	`LineOfCredit`	$2.00M	USD	Point-in-time
Deferred franchise fee revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$13.60M	USD	Point-in-time
Deferred franchise fee revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$14.16M	USD	Point-in-time
Upfront regional developer fees, net of current portion	`UpfrontRegionalDeveloperFeesNoncurrent`	$1.02M	USD	Point-in-time
Upfront regional developer fees, net of current portion	`UpfrontRegionalDeveloperFeesNoncurrent`	$1.50M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.24M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.29M	USD	Point-in-time
Total liabilities	`Liabilities`	$60.90M	USD	Point-in-time
Total liabilities	`Liabilities`	$62.38M	USD	Point-in-time
Commitments and contingencies (note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2023 and 2022	`PreferredStockValue`	-	USD	Point-in-time
Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2023 and 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 20,000,000 shares authorized, 14,783,757 shares issued and 14,751,633 shares outstanding as of December 31, 2023 and 14,560,353 shares issued and 14,528,487 outstanding as of December 31, 2022	`CommonStockValue`	$14.78K	USD	Point-in-time
Common stock, $0.001 par value; 20,000,000 shares authorized, 14,783,757 shares issued and 14,751,633 shares outstanding as of December 31, 2023 and 14,560,353 shares issued and 14,528,487 outstanding as of December 31, 2022	`CommonStockValue`	$14.56K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$45.56M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$47.50M	USD	Point-in-time
Treasury stock 32,124 shares as of December 31, 2023 and 31,866 shares as of December 31, 2022, at cost	`TreasuryStockCommonValue`	$856.64K	USD	Point-in-time
Treasury stock 32,124 shares as of December 31, 2023 and 31,866 shares as of December 31, 2022, at cost	`TreasuryStockCommonValue`	$860.48K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-21.91M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-12.15M	USD	Point-in-time
Total The Joint Corp. stockholders' equity	`StockholdersEquity`	$24.75M	USD	Point-in-time
Total The Joint Corp. stockholders' equity	`StockholdersEquity`	$32.56M	USD	Point-in-time
Non-controlling Interest	`MinorityInterest`	$25.00K	USD	Point-in-time
Non-controlling Interest	`MinorityInterest`	$25.00K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$32.59M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$24.77M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.31M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$93.49M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$87.15M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$117.70M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$101.25M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$10.55M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$9.17M	USD	Annual
Selling and marketing expenses	`SellingAndMarketingExpense`	$16.54M	USD	Annual
Selling and marketing expenses	`SellingAndMarketingExpense`	$13.96M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$8.58M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$6.65M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$81.47M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$70.23M	USD	Annual
Total selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$106.59M	USD	Annual
Total selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$90.84M	USD	Annual
Net loss on disposition or impairment	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-410.21K	USD	Annual
Net loss on disposition or impairment	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-2.63M	USD	Annual
(Loss) income from operations	`OperatingIncomeLoss`	$828.25K	USD	Annual
(Loss) income from operations	`OperatingIncomeLoss`	$-2.07M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-133.10K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$3.71M	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$695.15K	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.64M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$68.45K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$11.39M	USD	Annual
Net (loss) income	`ProfitLoss`	$626.71K	USD	Annual
Net (loss) income	`ProfitLoss`	$-9.75M	USD	Annual
Basic (loss) earnings per share (in dollars per share)	`EarningsPerShareBasic`	$0.04	USD	Annual
Basic (loss) earnings per share (in dollars per share)	`EarningsPerShareBasic`	$-0.66	USD	Annual
Diluted (loss) earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$0.04	USD	Annual
Diluted (loss) earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$-0.65	USD	Annual
Basic weighted average shares (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	14.69M	shares	Annual
Basic weighted average shares (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	14.49M	shares	Annual
Diluted weighted average shares (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.87M	shares	Annual
Diluted weighted average shares (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.94M	shares	Annual

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-9.75M	USD	Annual
Net (loss) income	`NetIncomeLoss`	$626.71K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.58M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.65M	USD	Annual
Net loss on disposition or impairment (non-cash portion)	`GainLossOnDispositionOfAssets1`	$-2.63M	USD	Annual
Net loss on disposition or impairment (non-cash portion)	`GainLossOnDispositionOfAssets1`	$-410.21K	USD	Annual
Net franchise fees recognized upon termination of franchise agreements	`GainLossOnTerminationOfFranchisingAgreements`	$68.54K	USD	Annual
Net franchise fees recognized upon termination of franchise agreements	`GainLossOnTerminationOfFranchisingAgreements`	$217.83K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-441.35K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$10.90M	USD	Annual
Stock based compensation expense	`ShareBasedCompensation`	$1.74M	USD	Annual
Stock based compensation expense	`ShareBasedCompensation`	$1.27M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-192.35K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$154.67K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$341.48K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-183.41K	USD	Annual
Deferred franchise costs	`IncreaseDecreaseInContractWithCustomerAsset`	$351.15K	USD	Annual
Deferred franchise costs	`IncreaseDecreaseInContractWithCustomerAsset`	$-355.95K	USD	Annual
Deposits and other assets	`IncreaseDecreaseInDepositOtherAssets`	$189.18K	USD	Annual
Deposits and other assets	`IncreaseDecreaseInDepositOtherAssets`	$-1.49K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.38M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$818.26K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.17M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$793.68K	USD	Annual
Payroll liabilities	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$1.46M	USD	Annual
Payroll liabilities	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.88M	USD	Annual
Upfront regional developer fees	`IncreaseDecreaseInRegionalDeveloperFees`	$-598.78K	USD	Annual
Upfront regional developer fees	`IncreaseDecreaseInRegionalDeveloperFees`	$-1.29M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$301.10K	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$2.89M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$900.15K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$20.91K	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$14.68M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.21M	USD	Annual
Proceeds from sale of clinics	`ProceedsFromDivestitureOfBusinesses`	-	USD	Annual
Proceeds from sale of clinics	`ProceedsFromDivestitureOfBusinesses`	$105.20K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.90M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.90M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.19M	USD	Annual
Payments of finance lease obligation	`FinanceLeasePrincipalPayments`	$49.85K	USD	Annual
Payments of finance lease obligation	`FinanceLeasePrincipalPayments`	$24.43K	USD	Annual
Purchases of treasury stock under employee stock plans	`PaymentsForRepurchaseOfCommonStock`	$3.83K	USD	Annual
Purchases of treasury stock under employee stock plans	`PaymentsForRepurchaseOfCommonStock`	$5.80K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$202.39K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$384.27K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$328.61K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$174.12K	USD	Annual
Increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.66M	USD	Annual
Increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-9.36M	USD	Annual
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.91M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.75M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.15M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.06M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$805.35K	USD	Point-in-time
Cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.21M	USD	Point-in-time
Cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.55M	USD	Point-in-time
Cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.91M	USD	Point-in-time

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Balance, beginning common stock (in shares)	`CommonStockSharesOutstanding`	14.53M	shares	Point-in-time
Balance, beginning common stock (in shares)	`CommonStockSharesOutstanding`	14.75M	shares	Point-in-time
Balance, beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$32.59M	USD	Point-in-time
Balance, beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$24.77M	USD	Point-in-time
Balance, beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.31M	USD	Point-in-time
Balance, beginning treasury stock (in shares)	`TreasuryStockCommonShares`	32,124.00	shares	Point-in-time
Balance, beginning treasury stock (in shares)	`TreasuryStockCommonShares`	31,866.00	shares	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.27M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.74M	USD	Annual
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$384.27K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$202.39K	USD	Annual
Purchases of treasury stock under employee stock plans	`TreasuryStockValueAcquiredCostMethod`	$3.83K	USD	Annual
Purchases of treasury stock under employee stock plans	`TreasuryStockValueAcquiredCostMethod`	$5.80K	USD	Annual
Net income (loss)	`ProfitLoss`	$626.71K	USD	Annual
Net income (loss)	`ProfitLoss`	$-9.75M	USD	Annual
Balance, ending common stock (in shares)	`CommonStockSharesOutstanding`	14.53M	shares	Point-in-time
Balance, ending common stock (in shares)	`CommonStockSharesOutstanding`	14.75M	shares	Point-in-time
Balance, ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$32.59M	USD	Point-in-time
Balance, ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$24.77M	USD	Point-in-time
Balance, ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.31M	USD	Point-in-time
Balance, ending treasury stock (in shares)	`TreasuryStockCommonShares`	32,124.00	shares	Point-in-time
Balance, ending treasury stock (in shares)	`TreasuryStockCommonShares`	31,866.00	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.